Sept. 4 (UPI) -- A study of a pharmaceutical form of the psychedelic drug lysergic acid diethylamide suggests it might relieve anxiety symptoms for up to three months.
The results of a preliminary study on the effects of MM120, which is an oral form of LSD, show that a single dose could lessen the symptoms of generalized anxiety disorder, according a study published on Thursday in the Journal of the American Medical Association, USA Today reported.
Researchers at New York-based biotech company MindMed conducted the study on 198 adults who were diagnosed with generalized anxiety disorder.
"Ours is the first modern trial to look specifically at LSD, or any psychedelic, for generalized anxiety disorder," MindMed's Dan Karlin told New Scientist.
Related
